Clinical Trial Update: QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors [Phase 2]

View source ↗

Summary

Phase 2 results for AMG 479 in relapsed or refractory Ewing sarcoma family tumors, including Askin's tumor and desmoplastic small round cell tumor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Askin Tumor
• Desmoplastic Small Round Cell Tumor
• Ewing Sarcoma
• Ewing Sarcoma Family of Tumors
• Extraskeletal Ewing Sarcoma
• Primitive Neuroectodermal Tumor

Drugs mentioned

• AMG 479

Snippet

Sponsor: NantCell, Inc. | Conditions: Askin's Tumors, Desmoplastic Small Round Cell Tumors | Phase 2 | Status: COMPLETED